Guy Barker

Find an error

Name:
Organization: University of Warwick , England
Department: School of Life Sciences
Title: (PhD)
Co-reporter:Dr. John O. Suberu;Dr. Isolda Romero-Canelón;Dr. Neil Sullivan; Alexei A. Lapkin;Dr. Guy C. Barker
ChemMedChem 2014 Volume 9( Issue 12) pp:2791-2797
Publication Date(Web):
DOI:10.1002/cmdc.201402285

Abstract

In parts of Africa and Asia, self-medication with a hot water infusion of Artemisia annua (Artemisia tea) is a common practice for a number of ailments including malaria and cancer. In our earlier work, such an extract showed better potency than artemisinin alone against both chloroquine-sensitive and -resistant parasites. In this study, in vitro tests of the infusion in MCF7 cells showed high IC50 values (>200 μM). The combination of artemisinin and 3-caffeoylquinic acid (3CA), two major components in the extract, was strongly antagonistic and gave a near total loss of cytotoxicity for artemisinin. We observed that the interaction of 3CAs with another cytotoxic compound, cisplatin, showed potentiation of activity by 2.5-fold. The chelation of cellular iron by 3CA is hypothesized as a possible explanation for the loss of artemisinin activity.

Co-reporter:John Suberu, Lijiang Song, Susan Slade, Neil Sullivan, Guy Barker, Alexei A. Lapkin
Journal of Pharmaceutical and Biomedical Analysis 2013 Volume 84() pp:269-277
Publication Date(Web):October 2013
DOI:10.1016/j.jpba.2013.06.025
•We developed a rapid method of analysis of six metabolites in A. annua extracts.•9-Epi-artemisinin was quantified in raw extracts of A. annua for the first time.•We show the method to be robust, sensitive, adequate for high throughput analysis.A rapid high-pressure liquid chromatography (HPLC) tandem mass spectrometry (TQD) method for the determination of artemisinin, 9-epi-artemisinin, artemisitene, dihydroartemisinic acid, artemisinic acid and arteannuin B in Artemisia annua extracts is described. Detection and quantification of 9-epi-artemisinin in crude extracts are reported for the first time. In this method all six metabolites are resolved and eluted within 6 min with minimal sample preparation. A recovery of between 96.25% and 103.59% was obtained for all metabolites analysed and the standard curves were linear (r2 > 0.99) over the concentration range of 0.15–10 μg mL−1 for artemisinin, 9-epi-artemisinin, artemisitene and arteannuin B, and the range of 3.75–120 μg mL−1 for dihydroartemisinic acid and artemisinic acid. All validation indices were satisfactory, showing the method to be robust, quick, sensitive and adequate for a range of applications including high throughput (HTP) analysis.A rapid method for quantification of several important co-metabolites of artemisinin in raw extracts is presented.
Co-reporter:John O. Suberu, Peyman Yamin, Kai Leonhard, Lijiang Song, Smain Chemat, Neil Sullivan, Guy Barker, Alexei A. Lapkin
Journal of Biotechnology (10 February 2014) Volume 171() pp:25-33
Publication Date(Web):10 February 2014
DOI:10.1016/j.jbiotec.2013.11.024
•Co-metabolites negatively impacting crystallization of artemisinin were identified.•Flavonoid artemetin has strongest impact on crystallization of artemisinin.•Elevated levels of artemetin were found in the problematic East African biomass.Methoxylated flavonoids casticin, artemetin and retusin were identified as putative causative factors for low crystallization yields of artemisinin from extracts. Comparative profiling of biomass grown in different countries found elevated levels (∼60% higher) of artemetin in the East African biomass, which also demonstrates poor crystallization yields. The single compound and the combined doping experiments at 0, 25 and 50 μg mL−1 doping levels showed that artemetin (at 50 μg mL−1) caused a reduction in the amount of artemisinin crystallized by ca. 60%. A combination of the three flavonoids at 50 μg mL−1 almost completely inhibited crystallization, reducing the yield by 98%. Treatment of extracts by adsorbents efficiently resolves the problem of low crystallization yield.
2-Pentanol, 1,1,1-trichloro-4-methyl-
1,4-Cyclohexadiene-1-propanol, 4-methoxy-
Phenol, 2-[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-4,6-bis(1,1-dimethylethyl)-
2-Piperidinone, 5-ethyl-1-(phenylmethyl)-
9-Anthracenepropanoic acid, methyl ester
1,6-Hexanediol, 1-phenyl-
2-Pyridinecarboxaldehyde, phenylhydrazone
Piperidine, 2,5,5-trimethyl-
1,4-Cyclohexadiene-1-propanal
2-Pentanone, 1,1,1-trichloro-4-methyl-